Pathogendx Inc.
Tucson, AZ
- UEI
- F5MNXH19HA55
- CAGE
- 7JSD2
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
-
- 325411 Medicinal and Botanical Manufacturing
- 325414 Biological Product (except Diagnostic) Manufacturing
- 334516 Analytical Laboratory Instrument Manufacturing
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- 541990 All Other Professional, Scientific, and Technical Services
- 621511 Medical Laboratories
- 926140 Regulation of Agricultural Marketing and Commodities
- SAM.gov registration date
- Physical address
- 1230 E Pennsylvania St #102, Tucson, AZ 85714, USA
- Website
- pathogendx.com
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Radx tech project no. 2643 - pathogendx, INC. - pathogendx covid-19 microarray clade variant detection technology | National Heart Lung and Blood Institute (NIH) | $9,509,707 |
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Clear Labs Inc. | San Carlos, CA | 621511 Medical Laboratories |
| Visby Medical, Inc. | San Jose, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Gate Scientific, Inc. | Milpitas, CA | 334516 Analytical Laboratory Instrument Manufacturing |
| Color Genomic Danny | Burlingame, CA | 541990 All Other Professional, Scientific, and Technical Services |
| Innotech Precision Medicine, Inc. | Boston, MA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Pathogendx Inc. is a company that provides accurate and flexible pathogen testing technology for the cannabis, life sciences, and food industries. They deliver disruptive testing technology and solutions to the botanical, food, and agricultural markets.
Pathogendx Inc. has received prime federal contract awards to provide its pathogen detection technologies to support the federal government's COVID-19 response efforts. In February 2021, the company was awarded a $9,509,707 definitive firm fixed price contract by the National Institutes of Health's National Heart, Lung and Blood Institute to deliver its COVID-19 microarray clade variant detection technology under project number 2643. As a self-certified small disadvantaged business, Pathogendx provided its pathogen detection array to track genetic variants of SARS-CoV-2, with performance occurring in Scottsdale, Arizona through February 2023. No set-aside designation was applied to this award to the manufacturer Pathogendx.
Pathogendx Inc. has also received prime federal grant awards to support the development of its clinical diagnostic tests for SARS-CoV-2. In August 2020, the company received a $2,594,470.53 project grant from the National Institutes of Health's National Institute of Allergy and Infectious Diseases for the "Development or Improvement of Clinical Diagnostic Tests for SARS-CoV-2 to Increase the Sensitivity, Specificity and Ability to Provide Rapid Results." Additionally, Pathogendx has been a sub-grantee partner on a project with the University of Massachusetts Medical School to conduct clinical studies on multiple new point-of-care testing devices for COVID-19 in diverse populations and settings across the United States.
Quick answers
Is Pathogendx Inc. registered in SAM.gov?
Yes. Pathogendx Inc.'s SAM.gov registration is active through January 4, 2027.
What is Pathogendx Inc.'s most recent federal award?
Pathogendx Inc.'s most recent federal contract award is Radx tech project no. 2643 - pathogendx, INC. - pathogendx covid-19 microarray clade variant detection technology (75N92021C00001), from National Heart Lung and Blood Institute (NIH), on February 22, 2021.
On GovTribe
See Pathogendx Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors